Amy Ko
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 23
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 9
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 4
-
- Lung Cancer Treatments and Mutations 16
- Co-authors
- Ann Mullally (7 shared papers)Edwin Chen (6 shared papers)Shannon Elf (5 shared papers)Rebekka K. Schneider (3 shared papers)Emily A. Rosen (3 shared papers)Nouran S. Abdelfattah (4 shared papers)Mark A. Socinski (10 shared papers)Silvia Giannini (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Blood (5 papers)Journal of Thoracic Oncology (4 papers)Annals of Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Amy Ko
38 papers receiving 691 citations
Peers
Comparison fields: 5 of 69
- Genetics 312
- Hematology 278
- Internal Medicine 38
- Oncology 201
- Rheumatology 80
Countries citing papers authored by Amy Ko
This map shows the geographic impact of Amy Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ko more than expected).
Fields of papers citing papers by Amy Ko
This network shows the impact of papers produced by Amy Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ko. The network helps show where Amy Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 189 | |
| 2 | 2014 | 72 | |
| 3 | 2017 | 65 | |
| 4 | 2010 | 43 | |
| 5 | 2008 | 42 | |
| 6 | 2014 | 34 | |
| 7 | 2014 | 32 | |
| 8 | 2015 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2015 | 24 | |
| 11 | 2014 | 23 | |
| 12 | 2015 | 23 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2011 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2013 | 7 | |
| 19 | 2007 | 6 | |
| 20 | 2017 | 5 |
About Amy Ko
Amy Ko is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Hematology, having authored 38 papers that have together received 699 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (9 papers), Cancer Genomics and Diagnostics (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Genetics (312 citations), Hematology (278 citations), Internal Medicine (38 citations), Oncology (201 citations) and Rheumatology (80 citations). Amy Ko has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Ann Mullally, Edwin Chen, Shannon Elf, Rebekka K. Schneider, Emily A. Rosen, Nouran S. Abdelfattah, Mark A. Socinski, Silvia Giannini, Markus F. Renschler and Elizabeth A. Morgan. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Thoracic Oncology, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.